Search the Newsreel

Perella Weinberg Partners Q2 Earnings Call Highlights

Perella Weinberg Partners Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Perella Weinberg Partners (NASDAQ:PWP) Shares Gap Up Following Better-Than-Expected Earnings

Perella Weinberg Partners (PWP) Earnings Date and Reports 2026

Perella Weinberg (NASDAQ:PWP) Delivers Impressive Q2 CY2026

Perella Weinberg (NASDAQ:PWP) Delivers Impressive Q2 CY2026 Financial advisory firm Perella Weinberg Partners (NASDAQ:PWP) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales were flat year on year at $156.5 million. Its non-GAAP profit of $0.20 per share was significantly above …

Why Perella Weinberg (PWP) Stock Is Trading Up Today

Why Perella Weinberg (PWP) Stock Is Trading Up Today What Happened? Shares of financial advisory firm Perella Weinberg Partners (NASDAQ:PWP) jumped 17.5% in the morning session after the company reported second-quarter results that crushed Wall Street's profit expectations. The company announced adjusted earnings per …

Perella Weinberg Partners (NASDAQ:PWP) Issues Quarterly Earnings Results

What Has Changed for Aurelia Metals (ASX:AMI)?

Bank of Ireland Group PLC (BIRG.SG) Q2 FY2026 earnings call transcript

Earnings call transcript: Bank of Ireland lifts 2026 outlook after strong H1

Franklin Wireless Corp (FKWL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Franklin Wireless Corp (FKWL), noting its current valuation score of 9.03 within the Communications & Networking industry. It highlights the company's negative P/E ratio of -37.55 and indicates that key valuation metrics such as P/E, P/B, P/S, …

Franklin Wireless Corp (FKWL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Franklin Wireless Corp (FKWL), detailing its current price momentum score as 2.96, ranking it low within the Communications & Networking industry. It highlights the stock's trading range between a resistance level of $2.49 and a support level …

Is Relay Therapeutics (RLAY) Turning Zovegalisib Updates Into a Credibility Test for Its Pipeline Strategy?

Relay Therapeutics is nearing its Q2 2026 earnings report, with significant investor attention on updates for its lead asset, zovegalisib, and other pipeline programs. Analysts are increasingly optimistic, anticipating strong earnings and progress in oncology and genetic disease trials. The company recently completed a …

Relay Therapeutics to report Q2 2026 results on Aug 6

Relay Therapeutics, Inc. (NASDAQ: RLAY) will announce its second-quarter 2026 financial results and corporate highlights after U.S. financial markets close on August 6, 2026. The clinical-stage precision medicine company focuses on developing therapies for cancer and genetic diseases, with its lead asset, zovegalisib, currently …

Reliance (RS) Could Be 4% Overvalued As Strong Q2 Earnings Draw Fresh Attention

Press Release: Reliance Global Group Reports Second Quarter 2026 Results and Accelerates AI-Driven Transformation

Reliance Global Group (NASDAQ: RELI) announced its financial results for the second quarter of 2026, highlighting significant revenue growth and a reduced net loss. The company is actively integrating AI into its operations to enhance efficiency and client satisfaction, particularly through its Reliz Insurance …

Reliance Global Q2 net loss narrows 26% to $2.0M on cost cuts

Reliance Global Group (NASDAQ: EZRA) reported a 26% reduction in its Q2 2026 net loss, narrowing it to $2.0 million from $2.7 million in the prior year, primarily due to disciplined cost management and lower non-cash share-based compensation. While commission income declined due to …

Earnings call transcript: Reliance Global cuts loss in Q2 2026 as AI push lifts hopes

Reliance Global Group (EZRA) narrowed its Q2 2026 net loss by 26% to $2.0 million, down from $2.7 million a year prior, driven by significant expense reductions and a strategic portfolio realignment. The insurance and technology company highlighted its advancements in AI, stating the …

Reliance Global Group, Inc. Q2 2026: Revenue $2.11M, EPS $(3.26) — 10-Q Summary

Reliance Global Group, Inc. reported its Q2 2026 financial results, showing revenue of $2.11M and a diluted loss per share of $(3.26), an improvement from the prior year. The company's revenue decreased year-over-year due to divestitures, but operating expenses also fell, contributing to improved …

Relay Therapeutics (RLAY) CFO sells 1,459 shares to cover taxes

Relay Therapeutics' CFO, Thomas Catinazzo, sold 1,459 shares of common stock at $18.61 per share on July 28, 2026. This transaction was solely to cover income tax withholding obligations from the vesting of 3,269 Restricted Stock Units (RSUs) and was conducted without his discretion, …

Relay Therapeutics to report Q2 results after markets close

Relay Therapeutics is scheduled to release its second-quarter 2026 financial results and provide a corporate update on August 6, 2026, after the U.S. market closes. This information was originally published by Relay Therapeutics Inc. via GlobeNewswire. The news brief was generated by Public Technologies …

Relay Therapeutics, Inc. (RLAY) insider sale covers RSU tax

Relay Therapeutics, Inc. President of R&D, Donald A. Bergstrom, sold 2,237 shares of common stock on July 28, 2026, at $18.61 per share. This sale was explicitly to cover income tax withholding obligations from the vesting of 5,012 Restricted Stock Units (RSUs) on July …

Relay Therapeutics schedules its next financial update for Aug. 6

Relay Therapeutics (Nasdaq: RLAY) will report its second quarter 2026 financial results and corporate highlights after the U.S. market closes on Thursday, August 6, 2026. This announcement from the clinical-stage small molecule precision medicine company provides investors and analysts with the upcoming earnings date. …

Relay Therapeutics (RLAY) officer has 748 shares sold to satisfy RSU tax

Relay Therapeutics' Chief Corporate Development Officer, Peter Rahmer, sold 748 shares of common stock at $18.61 per share on July 28, 2026. This sale was non-discretionary and executed to cover income tax withholding obligations from the vesting of 3,051 Restricted Stock Units (RSUs). After …

Reliance Global Begins Deploying AI for Insurance Workflow Automation

Reliance Global Group (NASDAQ: EZRA) reported its Q2 2026 financial results, which included a net loss reduction and a focus on accelerating its proprietary AI platform for insurance operations. The company launched an AI agent for secure browser automation and is deploying AI capabilities …

PRLD|Prelude Therapeutics Inc|Price:4.520|Chg%:+0.130

This article provides a comprehensive stock analysis of Prelude Therapeutics Inc (PRLD) by TradingKey, highlighting its healthy fundamentals, significant growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes high institutional ownership and multiple "Buy" ratings from analysts, with a …

Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026

Relay Therapeutics, Inc. (Nasdaq: RLAY) will release its second quarter 2026 financial results and corporate highlights after market close on Thursday, August 6, 2026. The company is a clinical-stage precision medicine company focused on developing therapies for cancer and genetic diseases, utilizing its Dynamo® …

Prelude Therapeutics Inc (PRLD) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Prelude Therapeutics Inc (PRLD), assigning it a score of 6.29 out of 385 in the Biotechnology & Medical Research industry. The company's financial status is deemed stable, but its operating efficiency is low. Key financial dimensions like …

RELX Group Number of Employees 2026 | Employee Count & Headcount Data

RELX Group Plc had approximately 12,602 employees worldwide as of March 2026, representing a 9.7% growth from 2023. The company is actively hiring, with 1,558 active job postings in 2026, a 47.0% increase from 2025. Its workforce is concentrated in the United States, United …

M N C Wireless Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2026

The Technical Signals Behind (GIII) That Institutions Follow

This article analyzes G-III Apparel Group Ltd. (NASDAQ: GIII) through the lens of institutional trading signals generated by AI models. It highlights strong sentiment supporting an overweight bias, outlines specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry/target/stop loss levels, and provides a …

Outgoing Cracker Barrel CEO to receive millions in severance pay

Julie Felss Masino, the outgoing CEO and president of Cracker Barrel Old Country Store Inc., is set to receive millions in severance pay along with protective services upon her departure. This news follows previous announcements related to Cracker Barrel's leadership changes and other business …

JBT Marel Corp (JBTM) Financial Health: Profitability & Balance Sheet Analysis

JBT Marel Corp (JBTM) currently has a financial score of 7.95, positioning it stably within the Machinery, Tools, Heavy Vehicles, Trains & Ships industry with high operating efficiency. The company's recent quarterly revenue surged by 9.59% year-over-year to $936.00M, while net profit saw a …

Ambarella, Inc. $AMBA Shares Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company significantly increased its stake in Ambarella, Inc. by 49.5% in the first quarter, now owning 1.59 million shares valued at $81.6 million. Despite institutional growth and a "Moderate Buy" consensus rating from analysts with an average price target of …

JBT Marel Corp (JBTM) Institutional Confidence

JBT Marel Corp (JBTM) has an institutional shareholding score of 10.00, placing it first among 180 companies in its industry for institutional confidence. Institutional shareholding increased by 11.05% quarter-over-quarter, with Chuck Royce being the largest shareholder. Major institutional investors include BlackRock, State Street, and …

Arrowstreet Capital Limited Partnership Sells 241,347 Shares of G-III Apparel Group, LTD. $GIII

Arrowstreet Capital Limited Partnership significantly reduced its stake in G-III Apparel Group by 23% in the first quarter, selling 241,347 shares but still retaining 808,011 shares valued at $22.4 million. Despite this, G-III Apparel Group reported strong quarterly results, topping analyst estimates for both …

Ambarella Inc (AMBA) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Ambarella Inc (AMBA), focusing on its P/E ratio and overall valuation score within the Semiconductors & Semiconductor Equipment industry. As of July 29, 2026, Ambarella Inc has a valuation score of 7.52, ranking 67 out of 105 in …